PURPOSE: Recurrent pathogenic copy number variants (pCNVs) have large-effect impacts on brain function and represent important etiologies of neurodevelopmental psychiatric disorders (NPDs), including autism and schizophrenia. Patterns of health care utilization in adults with pCNVs have gone largely unstudied and are likely to differ in significant ways from those of children. METHODS: We compared the prevalence of NPDs and electronic health record-based medical conditions in 928 adults with 26 pCNVs to a demographically-matched cohort of pCNV-negative controls from >135,000 patient-participants in Geisinger's MyCode Community Health Initiative. We also evaluated 3 quantitative health care utilization measures (outpatient, inpatient, and emergency department visits) in both groups. RESULTS: Adults with pCNVs (24.9%) were more likely than controls (16.0%) to have a documented NPD. They had significantly higher rates of several chronic diseases, including diabetes (29.3% in participants with pCNVs vs 20.4% in participants without pCNVs) and dementia (2.2% in participants with pCNVs vs 1.0% participants without pCNVs), and twice as many annual emergency department visits. CONCLUSION: These findings highlight the potential for genetic information-specifically, pCNVs-to inform the study of health care outcomes and utilization in adults. If, as our findings suggest, adults with pCNVs have poorer health and require disproportionate health care resources, early genetic diagnosis paired with patient-centered interventions may help to anticipate problems, improve outcomes, and reduce the associated economic burden.
PURPOSE: Recurrent pathogenic copy number variants (pCNVs) have large-effect impacts on brain function and represent important etiologies of neurodevelopmental psychiatric disorders (NPDs), including autism and schizophrenia. Patterns of health care utilization in adults with pCNVs have gone largely unstudied and are likely to differ in significant ways from those of children. METHODS: We compared the prevalence of NPDs and electronic health record-based medical conditions in 928 adults with 26 pCNVs to a demographically-matched cohort of pCNV-negative controls from >135,000 patient-participants in Geisinger's MyCode Community Health Initiative. We also evaluated 3 quantitative health care utilization measures (outpatient, inpatient, and emergency department visits) in both groups. RESULTS: Adults with pCNVs (24.9%) were more likely than controls (16.0%) to have a documented NPD. They had significantly higher rates of several chronic diseases, including diabetes (29.3% in participants with pCNVs vs 20.4% in participants without pCNVs) and dementia (2.2% in participants with pCNVs vs 1.0% participants without pCNVs), and twice as many annual emergency department visits. CONCLUSION: These findings highlight the potential for genetic information-specifically, pCNVs-to inform the study of health care outcomes and utilization in adults. If, as our findings suggest, adults with pCNVs have poorer health and require disproportionate health care resources, early genetic diagnosis paired with patient-centered interventions may help to anticipate problems, improve outcomes, and reduce the associated economic burden.
Authors: Hreinn Stefansson; Andreas Meyer-Lindenberg; Stacy Steinberg; Brynja Magnusdottir; Katrin Morgen; Sunna Arnarsdottir; Gyda Bjornsdottir; G Bragi Walters; Gudrun A Jonsdottir; Orla M Doyle; Heike Tost; Oliver Grimm; Solveig Kristjansdottir; Heimir Snorrason; Solveig R Davidsdottir; Larus J Gudmundsson; Gudbjorn F Jonsson; Berglind Stefansdottir; Isafold Helgadottir; Magnus Haraldsson; Birna Jonsdottir; Johan H Thygesen; Adam J Schwarz; Michael Didriksen; Tine B Stensbøl; Michael Brammer; Shitij Kapur; Jonas G Halldorsson; Stefan Hreidarsson; Evald Saemundsen; Engilbert Sigurdsson; Kari Stefansson Journal: Nature Date: 2013-12-18 Impact factor: 49.962
Authors: Kandamurugu Manickam; Monica R McClain; Laurie A Demmer; Sawona Biswas; Hutton M Kearney; Jennifer Malinowski; Lauren J Massingham; Danny Miller; Timothy W Yu; Fuki M Hisama Journal: Genet Med Date: 2021-07-01 Impact factor: 8.822
Authors: Brenda Finucane; Juliann M Savatt; Hermela Shimelis; Santhosh Girirajan; Scott M Myers Journal: Am J Med Genet A Date: 2021-03-05 Impact factor: 2.578
Authors: Elizabeth Kelly; Noah Ivers; Rami Zawi; Lianne Barnieh; Braden Manns; Diane L Lorenzetti; David Nicholas; Marcello Tonelli; Brenda Hemmelgarn; Richard Lewanczuk; Alun Edwards; Ted Braun; Kerry A McBrien Journal: Syst Rev Date: 2015-03-14
Authors: Tarjinder Singh; James T R Walters; Mandy Johnstone; David Curtis; Jaana Suvisaari; Minna Torniainen; Elliott Rees; Conrad Iyegbe; Douglas Blackwood; Andrew M McIntosh; Georg Kirov; Daniel Geschwind; Robin M Murray; Marta Di Forti; Elvira Bramon; Michael Gandal; Christina M Hultman; Pamela Sklar; Aarno Palotie; Patrick F Sullivan; Michael C O'Donovan; Michael J Owen; Jeffrey C Barrett Journal: Nat Genet Date: 2017-06-26 Impact factor: 38.330
Authors: Siddharth Srivastava; Jamie A Love-Nichols; Kira A Dies; David H Ledbetter; Christa L Martin; Wendy K Chung; Helen V Firth; Thomas Frazier; Robin L Hansen; Lisa Prock; Han Brunner; Ny Hoang; Stephen W Scherer; Mustafa Sahin; David T Miller Journal: Genet Med Date: 2019-06-11 Impact factor: 8.822
Authors: Jonathan S Packer; Evan K Maxwell; Colm O'Dushlaine; Alexander E Lopez; Frederick E Dewey; Rostislav Chernomorsky; Aris Baras; John D Overton; Lukas Habegger; Jeffrey G Reid Journal: Bioinformatics Date: 2015-09-17 Impact factor: 6.937